Closure
This article was originally published in The Tan Sheet
Executive Summary
Liquid Band-Aid manufacturer plans introduction of "five new Band-Aid products over the next several months," Closure CEO Daniel Pelak announces at UBS Warburg Global Life Sciences Conference in New York Sept. 24. Products will treat skin-cracking, acne and itching, Pelak says. Raleigh, N.C.-firm expects revenue of roughly $34 mil. for the year, with sales growth of 50% each quarter in 2003, driven largely by Dermabond Rx topical skin adhesive and Band-Aid liquid bandage, both marketed by Johnson & Johnson/Ethicon...